Steffan T Nawrocki

MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy

J. Carew, Steffan T Nawrocki, Patrick Griffin, 2012, Expert opinion on investigational drugs.

Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL.

Peng Huang, Michael J Keating, D. McConkey, 2006, Blood.

Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy.

Francis J Giles, F. Giles, J. Carew, 2008, Cancer letters.

Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia.

Francis J Giles, Peter G. Smith, J. Garnsey, 2010, Blood.

Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition)

Sangeeta Khare, Xin Qi, Ying Wang, 2016 .